Ticker Launch

SPAC · Merger completed

CM Life Sciences II Inc.

Business combination with SomaLogic, Inc.

CM Life Sciences II Inc. is a blank-check company (SPAC) that raised $75M in its initial public offering on Feb 24, 2021, listing on Nasdaq Capital Market. It completed its business combination with SomaLogic, Inc. on Sep 1, 2021; the combined company is SomaLogic, Inc. (SLGC). Adaptive Biotechnology led the IPO, with Vice Chairman of LetsGetChecked and Zymeworks. White & Case advised the SPAC and Skadden, Arps advised the underwriters on the IPO.

SomaLogic develops SomaSignal tests, determining their performance characteristics itself, and operates a CLIA-certified clinical laboratory. It is the target of a proposed business combination with a special purpose acquisition company.

Status
Merger completed
IPO date
Feb 24, 2021
IPO size
$75M
IPO exchange
Nasdaq Capital Market
Target
SomaLogic, Inc. (Old SomaLogic)
Announced
Mar 29, 2021
Closed
Sep 1, 2021
Combined company
SomaLogic, Inc. (SLGC)
IPO underwriters
Adaptive Biotechnology, Vice Chairman of LetsGetChecked and Zymeworks
SPAC counsel (IPO)
White & Case
Underwriters' counsel (IPO)
Skadden, Arps

More on this SPAC for subscribers

Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.

Then $99/month or $999/year. Cancel anytime.

Filings

Other deSPACs that closed in 2021